Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Endocrine-Related Cancer

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/ERC-07-0092PMID 18310280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.

  2007cited by this paper
• 5α‐Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production

  2007cited by this paper
• Highly sensitive determination of estrone and estradiol in human serum by liquid chromatography-electrospray ionization tandem mass spectrometry.

  2007cited by this paper
• Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

  2006cited by this paper
• The receptor expression pattern in ductal carcinoma in situ predicts recurrence.

  2006cited by this paper
• Biology of Ductal Carcinoma in Situ Classification Based on Biologic Potential

  2006cited by this paper
• Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium

  2006cited by this paper
• Prevention of hormone-related cancers: breast cancer.

  2005cited by this paper
• Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ

  2005cited by this paper
• Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001

  2005cited by this paper
• Estrogen-Responsive Finger Protein as a New Potential Biomarker for Breast Cancer

  2005cited by this paper
• Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ

  2005cited by this paper
• Sex steroid-producing enzymes in human breast cancer.

  2005cited by this paper
• Androgen Receptor Expression in Ductal Carcinoma In Situ of the Breast: Not a Helpful Marker for Classification Such as Estrogen Receptor α and Progesterone Receptor

  2005cited by this paper
• Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

  2005cited by this paper
• Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.

  2004cited by this paper
• Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

  2003cited by this paper
• Androgen receptors frequently are expressed in breast carcinomas

  2003cited by this paper
• Oestrogen receptor negativity as a marker for high‐grade ductal carcinoma in situ of the breast

  2003influential reference
• Treatment of DCIS--results from clinical trials.

  2003cited by this paper
• Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Breast cancer: from estrogen to androgen receptor

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.

  2002cited by this paper
• PKCθII, a New Isoform of Protein Kinase C Specifically Expressed in the Seminiferous Tubules of Mouse Testis*

  2001cited by this paper
• Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives.

  2001cited by this paper
• 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.

  2001cited by this paper
• Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation.

  2001cited by this paper
• Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation.

  2001cited by this paper
• Aromatase regulation and breast cancer

  2001cited by this paper
• Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.

  2001cited by this paper
• 17 β -Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters

  2000cited by this paper
• Risk of subsequent invasive breast cancer after breast carcinoma in situ.

  2000cited by this paper
• Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards.

  2000influential reference
• Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues.

  2000cited by this paper
• 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.

  2000cited by this paper
• Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells.

  1999cited by this paper
• Second cancers following in situ carcinoma of the breast

  1998cited by this paper
• Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.

  1998cited by this paper
• Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.

  1996cited by this paper
• Prognostic classification of breast ductal carcinoma-in-situ.

  1995cited by this paper
• Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues.

  1995cited by this paper
• Androgens induce divergent proliferative responses in human breast cancer cell lines.

  1995cited by this paper
• Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines.

  1992cited by this paper
• Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells.

  1991cited by this paper
• Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.

  1991cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Endogenous steroids in the pathophysiology of breast cancer.

  1989influential reference
• Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors

  1988cited by this paper
• Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors.

  1986cited by this paper

• Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer

  2024cites this paper
• Regulation of Stromal Cells by Sex Steroid Hormones in the Breast Cancer Microenvironment

  2024cites this paper
• Quantification of multiple steroid hormones in serum and human breast cancer tissue by liquid chromatography-tandem mass spectrometry analysis

  2024cites this paper
• Diverse role of androgen action in human breast cancer

  2022cites this paper
• A Novel AKR1C3 Specific Prodrug TH3424 With Potent Antitumor Activity in Liver Cancer

  2021cites this paper
• Hijacking Sexual Immuno-Privilege in GBM—An Immuno-Evasion Strategy

  2021cites this paper
• Overview of AKR1C3: Inhibitor Achievements and Disease Insights.

  2020cites this paper
• 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma

  2020cites this paper
• Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma In Situ of the Breast among UK Women

  2020influential citation
• Neuroimmunoendocrine Interactions in Tumorigenesis and Breast Cancer

  2019cites this paper
• Role of hydroxysteroid (17beta) dehydrogenase type 1 in reproductive tissues and hormone-dependent diseases.

  2019cites this paper
• Androgen excess in breast cancer development: implications for prevention and treatment.

  2019cites this paper
• The role of 17βHSDs in breast tissue and breast cancers.

  2019cites this paper
• Low-dose environmental endocrine disruptors, increase aromatase activity, estradiol biosynthesis and cell proliferation in human breast cells.

  2019cites this paper
• Androgen receptor: A promising therapeutic target in breast cancer

  2019cites this paper
• Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition

  2018cites this paper
• In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines

  2018cites this paper
• Hydroxysteroid (17beta) dehydrogenase 1 expression enhances estrogen action and serves as a potential drug target for reducing estrogen signaling in the uterus and mammary glands

  2018cites this paper
• DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells

  2018cites this paper
• Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile

  2018cites this paper
• Aromatase expression in atypical ductal hyperplasia in women

  2017cites this paper
• Clinical implications of estrone sulfate measurement in laboratory medicine

  2017cites this paper
• Heli Jokela: Outcome of Hsd17b1 gene deletion in ovarian and adipose tissue function

  2017cites this paper
• Steroid metabolism in breast cancer: Where are we and what are we missing?

  2017cites this paper
• The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma.

  2017cites this paper
• Ki‐67 Expression as a Factor Predicting Recurrence of Ductal Carcinoma In Situ of the Breast: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review

  2017cites this paper
• A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women

  2016cites this paper
• Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer

  2016cites this paper
• In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production.

  2016cites this paper
• Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.

  2016cites this paper
• Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas

  2016cites this paper
• Interplay between Tumor Microenvironment and Cancer Cells

  2016cites this paper
• Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208

  2015cites this paper
• The intracrinology of breast cancer.

  2015cites this paper
• 11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer.

  2015cites this paper
• Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.

  2015cites this paper
• A Survey of the Relationship between Serum Testosterone Level and Expressions of Androgen, Progesterone and Estrogen Receptors and HER2 in Iranian Women with Breast Cancer

  2015cites this paper
• Ineffective Inhibition of Aromatase: A Cause for AI Resistance?

  2015cites this paper
• Unravelling the link between insulin resistance and androgen excess

  2015cites this paper
• Correlation between mammographic breast density and expression of aromatase and 17 β hydroxysteroid dehydrogenase Type I ( 17 β HSD 1 ) in breast cancer

  2015cites this paper
• Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science.

  2015cites this paper
• Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes

  2014cites this paper
• Androgens in breast cancer 21 : 4 T 162 relevant levels in the circulation of women

  2014cites this paper
• Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.

  2014cites this paper
• Complexities of androgen receptor signalling in breast cancer.

  2014cites this paper
• Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast

  2014cites this paper
• The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer

  2014cites this paper
• The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue

  2013cites this paper
• Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

  2013cites this paper
• Androgen receptor in triple negative breast cancer.

  2013cites this paper
• Cell Polarity, Epithelial-Mesenchymal Transition, and Cell-Fate Decision Gene Expression in Ductal Carcinoma In Situ

  2012cites this paper
• Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma.

  2012cites this paper
• Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications

  2012cites this paper
• The diversity of sex steroid action: novel functions of hydroxysteroid (17β) dehydrogenases as revealed by genetically modified mouse models.

  2012cites this paper
• Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

  2012cites this paper
• Sex steroid synthesis in human skin in situ: the roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin.

  2012influential citation
• Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers

  2012cites this paper
• Steroid sulfatase and estrogen sulfotransferase in human carcinomas.

  2011cites this paper
• Expression of androgen receptor in breast cancer and its significance as a prognostic factor.

  2011cites this paper
• Circulating Sex Hormones and Tumor Characteristics in Postmenopausal Breast Cancer Patients. A Cross-Sectional Study

  2011cites this paper
• Oncologic risks of autologous fat grafting to the breast.

  2011cites this paper
• Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.

  2011cites this paper
• Immunolocalization of estrogen‐producing and metabolizing enzymes in benign breast disease: Comparison with normal breast and breast carcinoma

  2010cites this paper
• Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.

  2010cites this paper
• Aromatase and in situ estrogen production in DCIS (ductal carcinoma in situ) of human breast.

  2010cites this paper
• Testosterone membrane‐initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR

  2010cites this paper
• COMMON VARIATION IN THE FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) GENE, HORMONE THERAPY USE, AND MAMMOGRAPHIC BREAST DENSITY

  2010cites this paper
• The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum

  2010cites this paper
• Androgens in human breast carcinoma

  2010cites this paper
• The interaction between aromatase, metalloproteinase 2,9 and CD44 in breast cancer.

  2010cites this paper
• Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

  2010cites this paper
• Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry.

  2010cites this paper
• AROmAtAse expRessiOn in invAsive And in situ ductAlinOmAs pResent in the sAme bReAst

  2010cites this paper
• Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs.

  2009cites this paper
• Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer.

  2009cites this paper
• [Aromatase expression in invasive and in situ ductal carcinoma present in the same breast].

  2009cites this paper
• Role of human hydroxysteroid (17beta) dehydrogenase type 1 (HSD17B1) in steroid-dependent diseases in females –novel indications for HSD17B1 inhibitors. Phenotypic analysis of transgenic mice overexpressing human HSD17B1.

  2009cites this paper
• Expressão da aromatase em carcinomas de mama ductais invasivo e in situ presentes na mesma mama

  2009cites this paper
• Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

  2009cites this paper
• Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.

  2009cites this paper
• The Role of Androgens in Normal and Malignant Breast Tissue

  2008cites this paper
• Intratumoral estrogen production in breast carcinoma: significance of aromatase

  2008influential citation
• Carcinoma ductal breast . the InteractIon between aroMatase , MetalloproteInase 2 , 9 and cd 44 In breast cancer

  year unknowncites this paper